Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,996 | 7,383 | 9,364 | 6,049 | 186 |
| Receivables | 645 | 1,060 | 998 | 806 | 648 |
| TOTAL | $7,765 | $8,683 | $10,807 | $7,131 | $849 |
| Non-Current Assets | |||||
| Intangibles | 16,514 | 16,514 | 16,514 | 16,514 | 16,514 |
| Other Non-Current Assets | 192 | 199 | 209 | 0 | 0 |
| TOTAL | $16,706 | $16,713 | $16,723 | $16,514 | $16,514 |
| Total Assets | $24,470 | $25,396 | $27,530 | $23,645 | $17,363 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 692 | 499 | 508 | 481 | 824 |
| TOTAL | $700 | $516 | $516 | $781 | $824 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 300 | N/A |
| Other Non-Current Liabilities | 160 | 172 | 177 | 0 | 0 |
| TOTAL | $160 | $172 | $177 | $N/A | $N/A |
| Total Liabilities | $861 | $687 | $693 | $781 | $824 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,747 | 10,771 | 10,762 | 10,262 | N/A |
| Common Shares | 11 | 11 | 11 | 10 | 9 |
| Retained earnings | -21,276 | -18,958 | -15,891 | -15,499 | -13,598 |
| Other shareholders' equity | 42 | -5 | 31 | 4,682 | 4,683 |
| TOTAL | $23,610 | $24,709 | $26,837 | $22,864 | $16,540 |
| Total Liabilities And Equity | $24,470 | $25,396 | $27,530 | $23,645 | $17,363 |